|
Volumn 14, Issue 4, 2008, Pages 612-616
|
Quality of care for patients with inflammatory bowel disease in East China
|
Author keywords
Crohn's disease; Guidelines; Inflammatory bowel disease; Quality of care; Ulcerative colitis
|
Indexed keywords
AMINOSALICYLIC ACID DERIVATIVE;
ANTIBIOTIC AGENT;
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOSPORIN;
IMMUNOMODULATING AGENT;
INFLIXIMAB;
MERCAPTOPURINE;
MESALAZINE;
METHOTREXATE;
PREDNISOLONE;
SALAZOSULFAPYRIDINE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BONE MARROW TOXICITY;
CHINA;
CHINESE;
CLINICAL FEATURE;
COHORT ANALYSIS;
COLON CROHN DISEASE;
DEMOGRAPHY;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG WITHDRAWAL;
ENTERITIS;
FEMALE;
HEALTH CARE QUALITY;
HOSPITAL ADMISSION;
HOSPITAL CARE;
HUMAN;
LEUKOPENIA;
LIVER TOXICITY;
LOW DRUG DOSE;
MAJOR CLINICAL STUDY;
MALE;
OUTPATIENT CARE;
PATIENT ASSESSMENT;
PATIENT CARE;
PRACTICE GUIDELINE;
RETROSPECTIVE STUDY;
SMALL INTESTINE DISEASE;
ULCERATIVE COLITIS;
UNIVERSITY HOSPITAL;
|
EID: 40049109388
PISSN: 10079327
EISSN: None
Source Type: Journal
DOI: 10.3748/wjg.14.612 Document Type: Article |
Times cited : (8)
|
References (30)
|